Sumgen Biotech Sustainability Profile
Sumgen Biotech, a leading player in the biotechnology sector, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 2015, the company has rapidly established itself as a pioneer in the development of innovative biopharmaceuticals and advanced therapeutics. Specialising in monoclonal antibodies and gene therapies, Sumgen Biotech distinguishes itself through its commitment to cutting-edge research and development. The company’s unique approach to bioprocessing and its robust pipeline of products have garnered significant attention in the industry. With a strong market position, Sumgen Biotech has achieved notable milestones, including successful collaborations with global pharmaceutical firms and recognition for its contributions to healthcare advancements. As it continues to expand its influence, Sumgen Biotech remains dedicated to improving patient outcomes through its transformative solutions.
DitchCarbon Score
How does Sumgen Biotech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sumgen Biotech's score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sumgen Biotech's reported carbon emissions
Sumgen Biotech, headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges available at this time. This lack of data suggests that Sumgen Biotech may still be in the early stages of establishing its carbon management strategies or may not yet have publicly committed to specific climate initiatives. As the industry increasingly prioritises sustainability, it will be essential for Sumgen Biotech to develop and communicate its climate commitments to align with global standards and expectations.
How Carbon Intensive is Sumgen Biotech's Industry?
How Carbon Intensive is Sumgen Biotech's Location?
Sumgen Biotech's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sumgen Biotech has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
